These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22792564)

  • 1. Costs for traditional meds static while specialty drug costs soar.
    Manag Care; 2012 Jun; 21(6):47. PubMed ID: 22792564
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescription drug costs easier to swallow.
    State Legis; 2010 Apr; 36(4):10. PubMed ID: 20397320
    [No Abstract]   [Full Text] [Related]  

  • 3. Specialty pharmaceuticals increasingly administered in costly outpatient clinics.
    Manag Care; 2012 Jun; 21(6):44. PubMed ID: 22792563
    [No Abstract]   [Full Text] [Related]  

  • 4. Plenty of green in gray market. There's more at issue than just inflated prices for drugs in short supply.
    May D
    Mod Healthc; 2011 Oct; 41(42):25. PubMed ID: 22049782
    [No Abstract]   [Full Text] [Related]  

  • 5. Shades of gray. Secondary drug distributors raise questions.
    Lee J
    Mod Healthc; 2011 Oct; 41(41):10, 12. PubMed ID: 22111494
    [No Abstract]   [Full Text] [Related]  

  • 6. Prescription-price sticker shock: Will federal lawmakers intervene?
    Johnson SR
    Mod Healthc; 2015 Oct; 45(43):8-9. PubMed ID: 26619614
    [No Abstract]   [Full Text] [Related]  

  • 7. The costs of prescription drugs in the United States: Pharmacists' voices must be heard.
    Abramowitz PW; Cobaugh DJ
    Am J Health Syst Pharm; 2016 Apr; 73(8):515-6. PubMed ID: 27045059
    [No Abstract]   [Full Text] [Related]  

  • 8. The High Cost of Prescription Drugs in America.
    Sofer D
    Am J Nurs; 2016 Dec; 116(12):14. PubMed ID: 27875426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in pharmacoeconomic evaluation in Ireland.
    Tilson L; Barry M
    Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):221-4. PubMed ID: 20545585
    [No Abstract]   [Full Text] [Related]  

  • 10. Specialty pharmacy management will become more intense.
    Collins S
    Manag Care; 2010 Oct; 19(10):20-3. PubMed ID: 21049783
    [No Abstract]   [Full Text] [Related]  

  • 11. THE HIGH COST OF CURE: DOCTORS WADE INTO THE DRUG-PRICING BATTLES.
    Boerner H
    Physician Leadersh J; 2015; 2(5):46-8. PubMed ID: 26529877
    [No Abstract]   [Full Text] [Related]  

  • 12. Top pharmacists see rising prices, doubt fast takeoff for other trends.
    Manag Care; 2016 Apr; 25(4):50. PubMed ID: 27265972
    [No Abstract]   [Full Text] [Related]  

  • 13. Report: prescription costs soar, Congress should act.
    Wagner L; Packer J
    Mod Healthc; 1991 Sep; 21(39):10. PubMed ID: 10114141
    [No Abstract]   [Full Text] [Related]  

  • 14. Captive markets.
    Mettner J
    Minn Med; 2008 Nov; 91(11):12-3. PubMed ID: 19108536
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of newer drugs on health spending: do they really increase the costs?
    Civan A; Köksal B
    Health Econ; 2010 May; 19(5):581-95. PubMed ID: 19404925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Save Money on Your Meds: Prices can vary widely from store to store, even in the same town. The trick is to shop around.
    Consum Rep; 2016 Jan; 81(1):13-7. PubMed ID: 26738208
    [No Abstract]   [Full Text] [Related]  

  • 17. Copayment coupons undermine formularies.
    Manag Care; 2011 Dec; 20(12):63. PubMed ID: 22259878
    [No Abstract]   [Full Text] [Related]  

  • 18. Defying the prescription. Forget forecasts--drug sales soar under managed care.
    Hensley S
    Mod Healthc; 1998 Apr; 28(15):42. PubMed ID: 10178321
    [No Abstract]   [Full Text] [Related]  

  • 19. Despite high costs, specialty drugs may offer value for money comparable to that of traditional drugs.
    Chambers JD; Thorat T; Pyo J; Chenoweth M; Neumann PJ
    Health Aff (Millwood); 2014 Oct; 33(10):1751-60. PubMed ID: 25288419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How insurers' bargaining power affects drug prices in Medicare Part D.
    Natl Bur Econ Res Bull Aging Health; 2009; (4):1-2. PubMed ID: 20355274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.